- Condition: Gallstone Disease
Intervention: Procedure: Cholangiography during transvaginal rigid-hybdrid NOTES cholecystectomy
Sponsors: Cantonal Hosptal, Baselland; Cantonal Hosptal, Baselland
Recruiting - verified April 2012 - Conditions: Cholelithiasis; Surgery; Laparoscopy
Interventions: Procedure: SILS Cholecystectomy; Procedure: FSIS cholecystectomy
Sponsors: Hospital Son Llatzer; Jose F. Noguera; Hospital Mateo Orfila
Recruiting - verified March 2012 - Condition: Cholecystolithiasis
Interventions: Device: dissection of gallbladder in laparoscopic cholecystectomy; Device: dissection of gallbladder in laparoscopic cholecystectomy
Sponsors: Central Finland Hospital District; Central Finland Hospital District
Recruiting - verified March 2012 - The Effect of Transvaginal vs. Conventional Laparoscopic Cholecystectomy on the Postoperative CourseConditions: Cholecystolithiasis; Surgery; Pain
Intervention: Procedure: TV NOTES cholecystectomy
Sponsors: Herlev Hospital; Herlev Hospital; University of Copenhagen; University Hospital, Gentofte, Copenhagen; Bispebjerg Hospital
Not yet recruiting - verified April 2012 - Condition: Acute Cholecystitis
Intervention: Procedure: Laparoscopic cholecystectomy
Sponsors: University of Lausanne Hospitals; University of Lausanne Hospitals
Recruiting - verified March 2012 - Conditions: Gallbaldder Cancer; Gallstones
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI); Pontificia Universidad Catolica de Chile
Recruiting - verified October 2011 - Conditions: Cholelithiasis; Cholecystitis
Interventions: Procedure: Emergency cholecystectomy first; Procedure: Sequential common bile duct imaging/cholecystectomy
Sponsors: University Hospital, Geneva; University Hospital, Geneva
Recruiting - verified April 2012 - Condition: Biliary Tract (Intrahepatic, Extrahepatic Cholangiocarcinoma, Gall Bladder) Cancer
Interventions: Drug: Oxaliplatin; Drug: Oxaliplatin
Sponsors: Samsung Medical Center; Samsung Medical Center
Recruiting - verified February 2012 - Conditions: Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer
Interventions: Drug: Akt inhibitor MK2206; Genetic: mutation analysis; Genetic: proteomic profiling; Other: laboratory biomarker analysis; Other: pharmacogenomic studies; Other: pharmacological study
Sponsors: National Cancer Institute (NCI); Arthur G. James Cancer Hospital & Richard J. Solove Research Institute; National Cancer Institute (NCI)
Recruiting - verified August 2011 - Conditions: Cholelithiasis; Cholecystitis; Pancreatitis Biliary; Colic of Gallbladder Without Mention of Cholecystitis
Interventions: Drug: Indocyanine Green (ICG); Drug: Standard critical view technique
Sponsors: Maimonides Medical Center; Maimonides Medical Center
Recruiting - verified August 2011 - Condition: CHOLELITHIASIS
Interventions: Procedure: Single-port cholecystectomy; Procedure: Four-port laparoscopic cholecystectomy
Sponsors: Mayo Clinic; Mayo Clinic
Recruiting - verified January 2012 - Condition: Common Bile Duct Gallstones
Intervention: Procedure: Normal Saline Irrigation
Sponsors: Seoul National University Hospital; Seoul National University Hospital
Recruiting - verified August 2011 - A Novel Technique For Gall Bladder Fundus Retraction In Single Incision Laparoscopic CholecystectomyCondition: Gallbladder Diseases
Intervention: Procedure: cholecystectomy
Sponsors: Mansoura University; Mansoura University
Recruiting - verified January 2011 - Conditions: Gallbladder Disease; Biliary Colic; Gallstones
Intervention: Drug: Indocyanine green (ICG)
Sponsors: Intuitive Surgical; Intuitive Surgical; SS.Antonio e Biagio e Cesare Arrigo; University Hospital, Geneva
Recruiting - verified August 2011 - Condition: Cholecystitis
Intervention: Other: video
Sponsors: Kaohsiung Medical University Chung-Ho Memorial Hospital; Kaohsiung Medical University Chung-Ho Memorial Hospital
Recruiting - verified November 2011 - Conditions: Cholelithiasis; Cholecystectomy
Interventions: Procedure: Laparoscopic cholecystectomy; Procedure: Minilaparoscopic cholecystectomy
Sponsors: McGill University Health Center; McGill University Health Center
Recruiting - verified April 2012 - Condition: Biliary Carcinoma
Interventions: Drug: Panitumumab plus GEMOX chemotherapy; Drug: GEMOX chemotherapy
Sponsors: Fondazione del Piemonte per l'Oncologia; Prof. Massimo Aglietta
Recruiting - verified February 2012 - Conditions: Gallstone; Gallbladder Polyps
Interventions: Procedure: CLC; Procedure: TU-LESSC
Sponsors: Beijing Friendship Hospital; Beijing Friendship Hospital
Recruiting - verified October 2010 - Condition: Diabetes
Intervention:
Sponsors: University Hospital, Gentofte, Copenhagen; University Hospital, Gentofte, Copenhagen
Recruiting - verified May 2011 - Conditions: Bladder Cancer; Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer; Lung Cancer; Pancreatic Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter
Interventions: Drug: cisplatin; Drug: gemcitabine hydrochloride; Drug: veliparib; Other: laboratory biomarker analysis; Other: pharmacological study
Sponsors: National Cancer Institute (NCI); University of Pittsburgh; National Cancer Institute (NCI)
Recruiting - verified August 2011 - Conditions: Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer; Periampullary Adenocarcinoma
Interventions: Drug: AZD2171; Drug: mFOLFOX6
Sponsors: Case Comprehensive Cancer Center; Case Comprehensive Cancer Center; National Cancer Institute (NCI)
Recruiting - verified March 2012 - Condition: Gallstones
Intervention: Procedure: Transvaginal Cholecystectomy
Sponsors: Mayo Clinic; Mayo Clinic
Recruiting - verified November 2011 - Conditions: Biliary Tract Cancer; Gallbladder Cancer
Interventions: Drug: Panitumumab; Drug: oxaliplatin; Drug: gemcitabine
Sponsors: University of Rochester; University of Rochester; Amgen
Recruiting - verified November 2011 - Condition: Cholecystitis
Intervention: Procedure: NOTES assisted laparoscopic cholecystectomy
Sponsors: The Oregon Clinic; The Oregon Clinic; Northwestern University
Recruiting - verified October 2010 - Condition: Gall Bladder Diseases
Interventions: Procedure: NOTES Cholecystectomy; Procedure: Laparoscopic Cholecystectomy
Sponsors: Natural Orifice Surgery Consortium for Assessment and Research; Natural Orifice Surgery Consortium for Assessment and Research; American Society for Gastrointestinal Endoscopy
Recruiting - verified November 2011 - Conditions: Cholangiocarcinoma; Hepatobiliary Neoplasm; Liver Cancer; Bile Duct Cancer; Cancer of Gallbladder
Interventions: Procedure: Stereotactic Body Radiotherapy; Drug: Gemcitabine100 mg/m2; Drug: Cisplatin; Drug: Carboplatin; Drug: Capecitabine; Drug: 5FU
Sponsors: Stanford University; Stanford University
Recruiting - verified June 2011 - Condition: Cholelithiasis
Interventions: Procedure: Harmonic scalpel; Procedure: Traditional
Sponsors: University of Roma La Sapienza; University of Roma La Sapienza
Recruiting - verified February 2011 - Condition: Cholelithiasis
Interventions: Procedure: 4-Ports Cholecystectomy (4PC); Procedure: Single-Port Cholecystectomy (SPC)
Sponsors: European Association for Endoscopic Surgery; European Association for Endoscopic Surgery
Recruiting - verified December 2011 - Condition: Gall Stones
Intervention: Procedure: Laser Lithotripsy
Sponsors: The Cleveland Clinic; The Cleveland Clinic
Recruiting - verified April 2011 - Conditions: Acute Lithiasic Cholecystitis Grade I or II; Symptoms Lasting for Less Than 5 Days; Required Cholecystectomy; Preoperative Amoxicillin Clavulanic Acid for at Most 5 Days
Interventions: Drug: amoxicillin clavulanic acid; Drug: No medication
Sponsors: Centre Hospitalier Universitaire, Amiens; Centre Hospitalier Universitaire, Amiens
Recruiting - verified February 2012 - Condition: Cholangiocarcinoma
Intervention: Drug: Gemcitabine, Capecitabine and Bevacizumab
Sponsors: Roswell Park Cancer Institute; Roswell Park Cancer Institute; Genentech
Recruiting - verified December 2011 - Conditions: Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer; Pancreatic Cancer; Periampullary Adenocarcinoma; Small Intestine Cancer
Interventions: Drug: erlotinib hydrochloride; Drug: gemcitabine hydrochloride; Drug: oxaliplatin; Other: laboratory biomarker analysis
Sponsors: Vanderbilt-Ingram Cancer Center; Vanderbilt-Ingram Cancer Center; National Cancer Institute (NCI)
Recruiting - verified November 2011 - Conditions: Cholelithiasis; Biliary Dyskinesia
Intervention: Procedure: NOTES Transvaginal Cholecystectomy
Sponsors: Baystate Medical Center; Baystate Medical Center
Recruiting - verified June 2011 - Condition: Cholecystolithiasis
Interventions: Procedure: Single Trocar CCK; Procedure: Standard CCK
Sponsors: University of Lausanne Hospitals; University of Lausanne Hospitals
Recruiting - verified April 2012 - Conditions: Cholangiocarcinoma; Biliary Tract Cancer; Gallbladder Cancer
Interventions: Drug: Gemcitabine; Drug: Oxaliplatin; Drug: Sorafenib
Sponsors: University of Miami Sylvester Comprehensive Cancer Center; University of Miami Sylvester Comprehensive Cancer Center
Recruiting - verified March 2012 - Condition: Cholelithiasis
Intervention: Procedure: Laparoscopic-assisted transvaginal cholecystectomy
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified April 2012 - Condition: Cholelithiasis
Interventions: Procedure: Transvaginal hybrid NOTES cholecystectomy; Procedure: Cholecystectomy
Sponsors: Hospital Son Llatzer; Hospital Son Llatzer
Recruiting - verified March 2012 - Condition: Cancer
Interventions: Drug: hydroxychloroquine; Drug: sunitinib malate
Sponsors: University of Medicine and Dentistry New Jersey; University of Medicine and Dentistry New Jersey; National Cancer Institute (NCI)
Recruiting - verified October 2011 - Conditions: Extrahepatic Bile Duct Cancer; Gallbladder Cancer
Interventions: Drug: capecitabine; Drug: gemcitabine hydrochloride; Procedure: adjuvant therapy; Radiation: 3-dimensional conformal radiation therapy; Radiation: intensity-modulated radiation therapy
Sponsors: National Cancer Institute (NCI); Southwest Oncology Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Conditions: Pancreatic Cancer; Gastrointestinal Neoplasms; Colon Rectal Cancer Adenocarcinoma; Esophageal Cancer; Gall Bladder Cancer; Gastric (Stomach) Cancer; Gastrooesophageal Cancer; Gastrointestinal Stromal Tumor (GIST); Hepatobiliary Neoplasm; Liver Carcinoma; Gallbladder Carcinoma; Bile Duct Carcinoma; Carcinoma of the Large Intestine; Anal Cancer
Intervention: Procedure: Observation
Sponsors: Stanford University; Stanford University
Recruiting - verified June 2011 - Conditions: Biliary Tract Cancer; Gallbladder Cancer; Cancer Of The Extrahepatic Bile Duct; Ampullary Carcinoma
Interventions: Drug: ZD6474, Vandetanib; Drug: ZD6474, Vandetanib; Drug: Gemcitabine; Drug: Placebo matching ZD6474
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified March 2012 - Conditions: Gallbladder Disease; Pancreatitis
Intervention:
Sponsors: University of Alabama at Birmingham; Charles Mel Wilcox, MD
Recruiting - verified December 2011 - Conditions: Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Gastric Cancer; Lung Cancer; Melanoma; Non-Hodgkin's Lymphoma; Uterine Cancer; CORPUS UTERI,ENDOMETRIUM; LUNG; OVARY
Intervention:
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center
Recruiting - verified January 2012 - Conditions: Appendicitis; Cholelithiasis; Gallstones
Interventions: Procedure: Transvaginal Appendectomy; Procedure: Transvaginal Cholecystectomy
Sponsors: University of California, San Diego; University of California, San Diego
Recruiting - verified July 2011 - Conditions: Appendicitis; Cholelithiasis
Interventions: Procedure: Transgastric Appendectomy; Procedure: Transgastric Cholecystectomy
Sponsors: University of California, San Diego; University of California, San Diego
Recruiting - verified July 2011 - Conditions: Gallbladder Cancer; Cholangiocarcinoma; Biliary Tract Cancer
Intervention:
Sponsors: Indiana University; Indiana University School of Medicine
Recruiting - verified March 2012 - Condition: Gallbladder Cancer
Intervention: Procedure: Biliary stenting
Sponsors: All India Institute of Medical Sciences, New Delhi; All India Institute of Medical Sciences, New Delhi
Recruiting - verified January 2012 - Conditions: Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer
Interventions: Drug: capecitabine; Other: clinical observation; Procedure: adjuvant therapy
Sponsors: National Cancer Institute (NCI); Southampton University Hospitals NHS Trust
Recruiting - verified October 2011 - Condition: Cancer
Interventions: Drug: oxaliplatin; Procedure: management of therapy complications
Sponsors: National Cancer Institute (NCI); Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)
Recruiting - verified May 2007
 |
Join Clinical trials for Gallbladder |
